Small Bone
Innovations has a Humanitarian Device Exemption (HDE) from the FDA
to market or SR™MCP and SR™PIP Finger Joint Implants
as Humanitarian Use Devices (HUD). An HUD is a device that is intended
to benefit patients by treating a disease or condition that affects
fewer than 4,000 individuals in the United States per year. SBi
acquired this HDE with the acquisition of Avanta Orthopaedics.
A Humanitarian Use Device (HUD) is a legally marketed device. However,
an HUD may only be used in facilities that have established a local
institutional review board (IRB) and after an IRB has approved the
use of the device to treat or diagnose the specific disease.
IRB approval must be obtained prior to SBi distributing this product
to a physician. We must receive a copy of a letter from the IRB
at the institution where the surgeon intends to perform surgeries
granting approval for the physician to use this Humanitarian Use
Device.
A simple letter from the local IRB to the treating physician approving
the use of the device should at a minimum contain the following
information:
1. Hospital name, address, telephone number;
2. Doctor's name and address
3. A statement that the IRB has reviewed and is approving the use
of the Proximal Interphalangeal Joint (H980002) or Metacarpophalangeal
Joint (H010001) for the approved indications;
4. Signature of the IRB chairperson.
Humanitarian Device Exemption Information –
http://www.fda.gov/MedicalDevices/...default.htm
- H980002, 28-Sep-98 Avanta Proximal Interphalangeal (PIP) Finger
Prosthesis,
- H010001 28-Aug-01 Avanta Metacarpophalangeal (MCP) Finger Prosthesis.
HDE Regulation Questions and Answers
http://www.fda.gov/MedicalDevices/...ucm110194.htm
|